Subscribe

Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 11/28/24: Solving Clinical Technology Challenges with Integration & more

ByMiranda Schmalfuhs

November 28th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/27/24: Practical Gains for Pharma AI Use, Key Trends in the Evolution of PBMs & more

ByMiranda Schmalfuhs

November 27th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/26/24: Early Access for Innovative Therapies, Trump Names Picks for FDA and CDC & more

ByMiranda Schmalfuhs

November 26th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/25/24: Pharma Stilll Struggling with Digital Transformation, Removing Barriers to Gene Therapies & more

ByMiranda Schmalfuhs

November 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/22/24: Powering Pipelines Forward, Collabing for Better Patient Outcomes & more

ByMiranda Schmalfuhs

November 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/21/24: New Tricks to Solve Age-Old Problems, Medicare Open Enrollment Attracts Scammers & more

ByMiranda Schmalfuhs

November 21st 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/20/24: NIH Tests New PrEP Delivery Method, Empowerment in Patient-Focused Research & more

ByMiranda Schmalfuhs

November 20th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/19/24: Behind FDA PD-1 Inhibitor Label Restrictions, Email Reminders Improve Flu Shot Rates & more

ByMiranda Schmalfuhs

November 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/18/24: Bringing the Human Story to AI, Addressing Payer Coverage Challenges & more

ByMiranda Schmalfuhs

November 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/15/24: Practical Gains for Pharma AI Use, Small-Molecules Are More Cost Effective & more

ByMiranda Schmalfuhs

November 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/14/24: Powering Pipelines Forward, Debates Continue About Pharmacists’ Provider Status & more

ByMiranda Schmalfuhs

November 14th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/13/24: Strategies for Bridging the Sponsor-Site Tech Divide, Innovative Approaches to Chronic Disease Management & more

ByMiranda Schmalfuhs

November 13th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/12/24: Biotech Investor Sentiment Climbing Steadily, Vaccination Community Outreach Initiatives & more

ByMiranda Schmalfuhs

November 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/11/24: Advertising/Marketing Trends to Expect in Q1 of 2025, Understanding the Burnout Crisis & more

ByMiranda Schmalfuhs

November 11th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/8/24: Improving Health Outcomes While Reducing Costs, Addressing Racial Disparities in Opioid Prescriptions & more

ByMiranda Schmalfuhs

November 8th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/7/24: The Future of Financing Innovation, Homeless Doesn't Have To Mean Health Plan-Less & more

ByMiranda Schmalfuhs

November 7th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/6/24: Balancing Personalized Targeting with Protecting Consumers, What Do SMA Caregivers Want? & more

ByMiranda Schmalfuhs

November 6th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/5/24: Alternative Targeting Methods in a Post-Cookie World, Future Modalities for Infertility & more

ByMiranda Schmalfuhs

November 5th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/4/24: RWD Benefits in Privacy and Targeting, Challenges of Treating Type 1 Diabetes & more

ByMiranda Schmalfuhs

November 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/1/24: Targeting Patients Without Cookies, Personalized Diabetes Care Approaches & more

ByMiranda Schmalfuhs

November 1st 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/31/24: Addressing Supply Chain Challenges & Improving Patient Access, Why Health Literacy Needs a Digital Revolution & more

ByMiranda Schmalfuhs

October 31st 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/30/24: The State of Compounding, Apple’s AI Success Hinges on the iPhone & more

ByMiranda Schmalfuhs

October 30th 2024

The latest news for pharma industry insiders.

Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In

ByMiranda Schmalfuhs

October 30th 2024

In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.

Pharma Pulse 10/29/24: Strengthening Regulatory Framework for Compounded Medications, Cancer Disparities in Rural Areas & more

ByMiranda Schmalfuhs

October 29th 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/28/24: Identifying Illicit Actors vs Compound Pharmacies, Cancer Disparities in Rural Areas & more

ByMiranda Schmalfuhs

October 28th 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/25/24: Advantages & Disadvantages of Using Compounded Medications, Move Over, Dr. Google. ChatGPT, M.D., Has Better Answers & more

ByMiranda Schmalfuhs

October 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/24/24: Semaglutide Supply Chain & Access Challenges, Challenges in Adopting Novel Therapies & more

ByMiranda Schmalfuhs

October 24th 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/23/24: 2025 Marketing Trends to Expect, Controlling Cholesterol & more

ByMiranda Schmalfuhs

October 23rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/22/24: Blood Vessels Grown in a Lab, How Much Family Caregivers Would Make if Paid a Salary & more

ByMiranda Schmalfuhs

October 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/21/24: Measuring the ROI of Marketing Efforts, How Technology Benefits Specialty Pharmacy & more

ByMiranda Schmalfuhs

October 21st 2024

The latest news for pharma industry insiders.

© 2025 MJH Life Sciences^®

All rights reserved.